Status:
RECRUITING
Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
Lead Sponsor:
Centro Cardiopatici Toscani
Collaborating Sponsors:
Azienda USL 4 Prato
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
Brief Summary
Registration of all ACS patients (STEMI and NSTEMI) admitted to the cardiology ward and scheduled for early invasive strategy. The aim is to evaluate the protective effects of early (on admission) hig...
Detailed Description
Statin-naive patients and those on statin therapy with ACS who are admitted to the cardiology ward of our public (National Health Service) hospital and are scheduled for early invasive strategy receiv...
Eligibility Criteria
Inclusion
- Acute coronary syndrome (ST elevation and non ST elevation)
- Early invasive strategy
Exclusion
- contraindication to statin therapy
- refusal of consent
Key Trial Info
Start Date :
December 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT04087200
Start Date
December 1 2016
End Date
December 1 2026
Last Update
September 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiology Division, Prato Hospital
Prato, Italy, 59100